Century Therapeutics, Inc. reports $31.3 million Q1 loss
The company generated $1.70 million in quarterly revenue
By USInMinutes
Published - May 11, 2023, 03:06 PM ET
Last Updated - Aug 12, 2024, 08:22 AM EDT
Century Therapeutics, Inc. [IPSC] has reported fiscal Q1 loss of $31.30 million.
On a per-share basis, the DE based company said its diluted earnings are $0.53.
The Biological Products, Except Diagnostic Substances firm posted revenue of $1.70 million in this period.
